203 related articles for article (PubMed ID: 28209108)
1. Acute temozolomide induced liver injury : Mixed type hepatocellular and cholestatic toxicity.
Aygun C; Altınok AY; Çakır A; Agan AF; Balaban Y
Acta Gastroenterol Belg; 2016; 79(4):487-489. PubMed ID: 28209108
[TBL] [Abstract][Full Text] [Related]
2. Acute temozolomide induced liver injury: mixed type hepatocellular and cholestatic toxicity.
Aygun C; Altınok AY; Çakır A; Agan AF; Balaban Y
Acta Gastroenterol Belg; 2016; 79(2):363-365. PubMed ID: 27821033
[TBL] [Abstract][Full Text] [Related]
3. Clindamycin-induced acute cholestatic hepatitis.
Aygun C; Kocaman O; Gurbuz Y; Senturk O; Hulagu S
World J Gastroenterol; 2007 Oct; 13(40):5408-10. PubMed ID: 17879418
[TBL] [Abstract][Full Text] [Related]
4. Thioctic acid-induced acute cholestatic hepatitis.
Ridruejo E; Castiglioni T; Silva MO
Ann Pharmacother; 2011 Jul; 45(7-8):e43. PubMed ID: 21672886
[TBL] [Abstract][Full Text] [Related]
5. Temozolomide induced liver injury.
Dixit S; Hingorani M; Afzal P; Campbell AP
Acta Neurol Belg; 2011 Sep; 111(3):249-51. PubMed ID: 22141295
[TBL] [Abstract][Full Text] [Related]
6. Fenofibrate-induced acute cholestatic hepatitis.
Ho CY; Kuo TH; Chen TS; Tsay SH; Chang FY; Lee SD
J Chin Med Assoc; 2004 May; 67(5):245-7. PubMed ID: 15357112
[TBL] [Abstract][Full Text] [Related]
7. Severe cholestatic hepatitis due to temozolomide: an adverse drug effect to keep in mind. Case report and review of literature.
Grieco A; Tafuri MA; Biolato M; Diletto B; Di Napoli N; Balducci N; Vecchio FM; Miele L
Medicine (Baltimore); 2015 Mar; 94(12):e476. PubMed ID: 25816026
[TBL] [Abstract][Full Text] [Related]
8. Valproic acid related idiosyncratic drug induced hepatotoxicity in a glioblastoma patient treated with temozolomide.
Neyns B; Hoorens A; Stupp R
Acta Neurol Belg; 2008 Dec; 108(4):131-4. PubMed ID: 19239041
[TBL] [Abstract][Full Text] [Related]
9. Temozolomide-induced liver damage. A case report.
Becker F; Hecht M; Schmidtner J; Semrau S; Fietkau R
Strahlenther Onkol; 2014 Apr; 190(4):408-10. PubMed ID: 24452817
[TBL] [Abstract][Full Text] [Related]
10. Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system.
Sarganas G; Orzechowski HD; Klimpel A; Thomae M; Kauffmann W; Herbst H; Bronder E; Garbe E
Neuro Oncol; 2012 May; 14(5):541-6. PubMed ID: 22394496
[TBL] [Abstract][Full Text] [Related]
11. The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity.
Robles-Diaz M; Garcia-Cortes M; Medina-Caliz I; Gonzalez-Jimenez A; Gonzalez-Grande R; Navarro JM; Castiella A; Zapata EM; Romero-Gomez M; Blanco S; Soriano G; Hidalgo R; Ortega-Torres M; Clavijo E; Bermudez-Ruiz PM; Lucena MI; Andrade RJ; ;
Liver Int; 2015 Nov; 35(11):2474-82. PubMed ID: 25809419
[TBL] [Abstract][Full Text] [Related]
12. Risk of severe acute liver injury among patients with brain cancer treated with temozolomide: a nested case-control study using the healthcore integrated research database.
Desai VCA; Quinlan SC; Deitz AC; He J; Holick CN; Lanes S
J Neurooncol; 2017 Aug; 134(1):89-95. PubMed ID: 28717885
[TBL] [Abstract][Full Text] [Related]
13. Acute liver injury induced by levetiracetam and temozolomide co-treatment.
Khoury T; Chen S; Abu Rmeileh A; Daher S; Yaari S; Benson AA; Cohen J; Mizrahi M
Dig Liver Dis; 2017 Mar; 49(3):297-300. PubMed ID: 28034663
[TBL] [Abstract][Full Text] [Related]
14. Possible metformin-induced hepatotoxicity.
Kutoh E
Am J Geriatr Pharmacother; 2005 Dec; 3(4):270-3. PubMed ID: 16503324
[TBL] [Abstract][Full Text] [Related]
15. Drug-induced cholestatic hepatitis: how late can it occur even after the cessation of the culpable drug?
Zamani N; Mohammad Alizadeh A
Neuro Oncol; 2012 Jul; 14(7):830. PubMed ID: 22544734
[No Abstract] [Full Text] [Related]
16. Temozolomide-induced biliary ductopenia: a case report.
Balakrishnan A; Ledford R; Jaglal M
J Med Case Rep; 2016 Feb; 10():33. PubMed ID: 26846183
[TBL] [Abstract][Full Text] [Related]
17. Vanishing bile duct syndrome in the context of concurrent temozolomide for glioblastoma.
Mason M; Adeyi O; Fung S; Millar BA
BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25432915
[TBL] [Abstract][Full Text] [Related]
18. Acute cholestatic liver injury caused by polyhexamethyleneguanidine hydrochloride admixed to ethyl alcohol.
Ostapenko YN; Brusin KM; Zobnin YV; Shchupak AY; Vishnevetskiy MK; Sentsov VG; Novikova OV; Alekseenko SA; Lebed'ko OA; Puchkov YB
Clin Toxicol (Phila); 2011 Jul; 49(6):471-7. PubMed ID: 21761961
[TBL] [Abstract][Full Text] [Related]
19. Hepatotoxicity by combination treatment of temozolomide, artesunate and Chinese herbs in a glioblastoma multiforme patient: case report review of the literature.
Efferth T; Schöttler U; Krishna S; Schmiedek P; Wenz F; Giordano FA
Arch Toxicol; 2017 Apr; 91(4):1833-1846. PubMed ID: 27519711
[TBL] [Abstract][Full Text] [Related]
20. Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience.
Jalali R; Basu A; Gupta T; Munshi A; Menon H; Sarin R; Goel A
Br J Neurosurg; 2007 Dec; 21(6):583-7. PubMed ID: 18071985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
